Synthesis, structure, and in vitro and in vivo insulinomimetic activities of the zinc(II)-6-ethylpicolinate complex

Bulletin of the Chemical Society of Japan

Volumn 78, Issue 3, 2005, Pages 451-455

  Kojima, Yoshitane ^a   Yoshikawa, Yutaka ^a   Ueda, Eriko ^a   Kishimoto, Noriko ^a   Tadokoro, Makoto ^a   Sakurai, Hiromu ^b  

^a Osaka Prefecture University   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISEASE CONTROL; FATTY ACIDS; GLUCOSE; SOLUTIONS; SYNTHESIS (CHEMICAL); WATER; X RAY ANALYSIS;

EPINEPHRINE; FREE FATTY ACIDS (FFA); PYRIDINE RINGS; TRIGONAL BIPYRAMIDAL GEOMETRY;

ZINC COMPOUNDS;

ADRENALIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIS(6 ETHYLPICOLINATO)ZINC; CARBOXYLIC ACID; CHOLESTEROL; COORDINATION COMPOUND; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; NITROGEN; OXYGEN; PICOLINIC ACID DERIVATIVE; PYRIDINE; UNCLASSIFIED DRUG; UREA; WATER; ZINC COMPLEX; ZINC ION;

ADIPOCYTE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHEMICAL INTERACTION; CHOLESTEROL BLOOD LEVEL; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTALLIZATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON TRANSPORT; FATTY ACID TRANSPORT; GEOMETRY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; IC 50; IN VITRO STUDY; IN VIVO STUDY; INSULINOMIMETIC ACTIVITY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARAMETER; RAT; STRUCTURE ANALYSIS; UREA NITROGEN BLOOD LEVEL; X RAY CRYSTALLOGRAPHY;

EID: 16844375769     PISSN: 00092673     EISSN: None     Source Type: Journal    
DOI: 10.1246/bcsj.78.451     Document Type: Article

References (22)

1. L. Coulston and P. Dandona, Diabetes, 29, 665 (1980).
2. M. M. James and S. C. Charles, J. Biol. Chem., 257, 4362 (1982).
3. A. Shisheva, D. Gefel, and Y. Schechter, Diabetes, 41, 982 (1992).
4. M. D. Chen, S. J. Liou, P. Y. Lin, V. C. Yang, P. S. Alexander, and W. H. Lin, Biol. Trace Elem. Res., 61, 303 (1998).
5. Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, H. Sakurai, and Y. Kojima, Chem. Lett., 2000, 874.
6. Y. Yoshikawa, E. Ueda, Y. Suzuki, N. Yanagihara, H. Sakurai, and Y. Kojima, Chem. Pharm. Bull., 49, 652 (2001).
7. E. Ueda, Y. Yoshikawa, N. Kishimoto, M. Tadokoro, N. Yanagihara, H. Sakurai, and Y. Kojima, Chem. Lett., 2001, 1184.
8. Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, H. Sakurai, and Y. Kojima, Biochem. Biophys. Res. Commun., 281, 1190 (2001).
9. Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, T. Takino, H. Sakurai, and Y. Kojima, J. Biol. Inorg. Chem., 7, 68, 560 (2002).
10. S. G. Davies and M. R. Shipton, J. Chem. Soc., Perkin Trans. 1, 1991, 501.
11. A. D. Campbell, E. Chan, S. Y. Choor, L. W. Deady, and R. A. Shanks, Aust. J. Chem., 24, 377 (1971).
12. M. Nakai, H. Watanabe, C. Fujisawa, T. Satoh, J. Takada, R. Matsushita, and H. Sakurai, Biol. Pharm. Bull., 18, 719 (1995).
13. S. Fujimoto, K. Fujii, H. Yasui, R. Matsushita, J. Takeda, and H. Sakurai, J. Clin. Biochem. Nutr., 23, 113 (1997).
14. E. Ueda, Y. Yoshikawa, N. Kishimoto, M. Tadokoro, H. Sakurai, N. Kajiwara, and Y. Kojima, Bull. Chem. Soc. Jpn., 77, 981 (2004).
15. H. Sakurai, Y. Kojima, Y. Yoshikawa, K. Kawabe, and H. Yasui, Coord. Chem. Rev., 226, 187 (2002).
16. H. Sakurai, Chem. Rec., 2, 237 (2002).
17. Y. Kojima, Y. Yoshikawa, E. Ueda, R. Ueda, S. Yamamoto, K. Kumekawa, N. Yanagihara, and H. Sakurai, Chem. Pharm. Bull., 51, 1006 (2003).
18. C. Hansch, P. P. Maloney, and T. Fujita, Nature, 194, 178 (1963).
19. C. Hansch and T. Fujita, J. Am. Chem. Soc., 86, 1616 (1964).
20. N. Kitazawa, T. Miura, M. Kako, M. Usami, K. Tanigawa, H. Ishida, and Y. Seino, Biol. Pharm. Bull., 19, 1078 (1996).
21. E. Bergstrom, O. Hernell, L. A. Persson, and B. Vessby, Metabolism, 45, 908 (1996).
22. H. Irie and W. Mori, Acta Pathol. Jpn., 36, 363 (1986).